Russia’s mRNA-based vaccine
Russia has announced the development of an mRNA-based cancer vaccine, with plans to distribute it free of charge starting in early 2025. Preclinical trials have indicated that the vaccine can inhibit tumor growth and prevent metastasis. Researchers have utilized artificial intelligence to expedite the creation of personalized versions of the vaccine, potentially reducing development time to under an hour. USA researchers are also developing vaccines for an array of different cancer, however how safe are mRNA-based vaccine? The video links in the attached document digs deeper into this question.
